查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1950493

全球關節持續被動式鍛鍊器市場按類型、地區、最終用戶和分銷管道分類，2026-2032年預測

Joint Continuous Passive Motion Machine Market by Type, Target Area, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年協作式連續被動運動設備市場價值為 3.4548 億美元，預計到 2026 年將成長至 3.7394 億美元，年複合成長率為 8.72%，到 2032 年將達到 6.2037 億美元。

關鍵市場統計數據
基準年 2025 3.4548億美元
預計年份：2026年 3.7394億美元
預測年份 2032 6.2037億美元
複合年成長率 (%) 8.72%

權威的脈絡化闡述了持續被動運動裝置在現代復健中的臨床意義、工作流程整合以及以病人為中心的益處

本導言旨在闡明理解關節持續被動運動（CPM）裝置在現代治療路徑中不斷演變的作用所需的臨床、操作和技術背景。這些裝置旨在促進解剖關節的受控被動運動，是復健治療、術後通訊協定和家庭復健計畫的交匯點。過去十年間，臨床醫生和裝置研發人員攜手合作，不斷改進裝置的人體工學設計、使用者介面和安全聯鎖裝置，從而提高患者的舒適度，同時縮短監督治療所需的時間。

全面探討設備工程、數位連接和不斷變化的護理服務模式如何重塑持續被動運動設備市場

設備設計、數位整合和護理模式創新的進步正在共同推動一場變革，重新定義人們對復健設備的期望。製造商正採用模組化設計和先進的運動控制技術，以適應不同的關節解剖結構和手術通訊協定，從而減少設置時間和臨床醫生的培訓負擔。同時，將感測器和連接功能引入持續被動運動（CPM）平台，可以客觀地追蹤關節活動範圍，使臨床醫生能夠制定個人化的治療方案，並以更透明的方式報告治療結果。

對近期關稅變化對連續被動運動裝置生態系統中零件採購、籌資策略和商業模式的影響進行分析評估

近期關稅政策的累積影響，對進口商品和零件造成了衝擊，給製造商、經銷商和採購機構帶來了新的營運考量。關稅調整改變了致動器、控制電子元件和特殊塑膠等關鍵零件的到岸成本，促使採購團隊重新審視供應商合約和整體擁有成本。為此，設備製造商正加快步伐，尋找替代供應商、實現關鍵零件的本地化生產，並重新設計組件，以減少對受關稅影響零件的依賴。

詳細的細分分析揭示了最終用戶環境、解剖應用部位、設備配置和分銷策略如何決定產品設計和商業化路徑。

關鍵細分分析揭示了最終用戶、應用場景、設備類型和分銷管道等方面的細微動態特性，這些特徵都會影響產品需求和商業性策略。按最終用戶分類，市場涵蓋診所、居家照護、醫院和復健中心。診所進一步細分為門診診所和復健診所，醫院則分為私人醫院和公立醫院。這種細分錶明，門診復健環境優先考慮緊湊的外形尺寸和快速安裝，而住院和醫院環境則重視與臨床工作流程的整合以及由醫護人員管理的安全功能。居家照護環境需要直覺的介面、清晰的安全連鎖裝置和遠端監控功能，以支援獨立使用或看護者輔助使用。

從區域比較觀點，闡述了不同主要區域的臨床標準、管理體制和買家偏好如何影響其應用和商業化策略。

區域趨勢對美洲、歐洲、中東和非洲以及亞太地區的臨床應用、監管要求和商業性執行都有顯著影響。在美洲，決策越來越注重跨學科醫療團隊的協作和報銷機制的協調，從而推動了對具有成熟功能和與臨床系統無縫互通性的醫療器材的需求。能夠簡化大規模醫療系統和門診網路採購流程的服務模式也備受青睞。

競爭對手洞察：模組化設計、臨床合作和服務導向經營模式如何在醫療設備市場實現永續差異化

對主要企業的深入分析凸顯了他們在產品開發、夥伴關係和服務差異化方面的策略方針，這些方針將影響他們的競爭地位。領先的醫療設備開發商正在投資模組化架構，以實現功能逐步升級，從而延長產品生命週期並簡化維護。他們還優先考慮人性化的設計，以減少臨床醫生的設置時間並提高患者在家中使用時的依從性，並融入了快速安裝支架、直覺操作和清晰的用戶反饋機制等功能。

為企業提供切實可行的策略和營運建議，以加速產品推廣應用、增強供應鏈韌性並展現臨床和商業性價值。

針對行業領導者的具體建議側重於產品、商業和營運措施，以深化市場進入並增強營運韌性。首先，優先考慮模組化設計和可配置軟體，以便在無需昂貴重新設計的情況下，實現針對門診、住院和居家照護等不同應用場景的設備變體。這種方法可以降低製造複雜性，加快部署速度，同時滿足多樣化的臨床需求。其次，投資於嵌入式感測器套件和可互通的數據平台，以提供客觀的恢復指標，使臨床醫生能夠制定個人化護理方案，並向支付者和採購委員會展示臨床價值。

我們採用嚴謹的多源調查方法，結合專家訪談、技術審查和供應鏈分析，以確保結論是基於證據且可重複。

我們的調查方法結合了多方面的證據基礎、系統性的專家參與和嚴謹的定性綜合分析，以確保獲得可靠且可操作的見解。主要資料來源包括對臨床醫生、採購經理、設備開發人員和復健專業人員的結構化訪談，以了解設備在實際應用中的表現、工作流程的限制以及推廣應用的促進因素。此外，我們也對設備規格、監管申報文件和臨床指導文件進行技術審查，以檢驗功能需求和合規性預期。

簡潔扼要的結論整合了決定連續被動運動 (CPM) 設備在不斷發展的領域中能否成功的技術、商業性和營運要素。

總之，持續被動運動裝置在現代復健體系中佔據著至關重要的地位，它連接著臨床通訊協定、患者體驗和不斷發展的醫療服務模式。裝置工程和數位化整合技術的進步正在拓展治療能力，同時也改變了採購需求和分銷管道的動態。關稅趨勢和供應鏈波動帶來了壓力，但也獎勵企業採用更具韌性的採購方式、模組化設計以及以服務為導向的商業模式。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 關節持續被動運動設備市場（按類型分類）

  • 雙面
  • 片面

第9章 按目標區域分類的聯合持續被動運動設備市場

  • 踝
  • 彎頭
  • 膝蓋
  • 肩膀

第10章 按最終用戶分類的聯合持續被動運動設備市場

  • 診所
    • 門診部
    • 復健診所
  • 居家照護
  • 醫院
    • 私立醫院
    • 公立醫院
  • 復健中心

第11章 按分銷管道分類的聯合連續被動運動設備市場

  • 直銷
  • 電子商務
    • 製造商官方網站
    • 網路藥房
  • 零售
  • 第三方經銷商
    • 授權經銷商
    • 獨立銷售代理

第12章 各地區聯合持續被動運動設備市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 聯合持續被動運動設備市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國聯合持續被動運動設備市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國聯合持續被動運動設備市場

第16章：中國關節持續被動運動設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Biodex Medical Systems, Inc.
  • Bio-Med Inc.
  • Bio-Medical Orthopaedic Equipment Suppliers
  • Breg, Inc.
  • Capital Medical Corporation
  • Chinesport SpA
  • DePuy Synthes, Inc.
  • DeRoyal Industries, Inc.
  • DJO LLC
  • Furniss Corporation
  • HMS Medical Systems
  • Kinex Medical Company, LLC
  • Mediware Information Systems, Inc.
  • Medi-Care Solutions Ltd.
  • Medline Industries, Inc.
  • OPED GmbH & Co. KG
  • OrthoAgility Ltd.
  • OrthoRehab, Inc.
  • Rehab-Robotics Company Limited
  • Smith & Nephew plc
  • Stryker Corporation
  • Surgi-Care, Inc.
  • TheraMotion, LLC
  • Zimmer Biomet Holdings, Inc.
  • Ossur hf
Product Code: MRR-4F7A6D4FD89C

The Joint Continuous Passive Motion Machine Market was valued at USD 345.48 million in 2025 and is projected to grow to USD 373.94 million in 2026, with a CAGR of 8.72%, reaching USD 620.37 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 345.48 million
Estimated Year [2026] USD 373.94 million
Forecast Year [2032] USD 620.37 million
CAGR (%) 8.72%

An authoritative contextual framing that explains clinical relevance, workflow integration, and patient-centered benefits of continuous passive motion devices within modern rehabilitation

The introduction establishes the clinical, operational, and technological context necessary to understand the evolving role of joint continuous passive motion (CPM) devices within contemporary care pathways. These devices, designed to facilitate controlled passive movement of anatomical joints, sit at the intersection of rehabilitative therapy, postoperative protocols, and home-based recovery programs. Over the past decade, clinicians and device developers have collaborated to refine device ergonomics, user interfaces, and safety interlocks that improve patient comfort while reducing time required for supervised therapy sessions.

This section situates CPM machines within multidisciplinary care, highlighting how surgeons, physical therapists, and home health providers integrate these tools into individualized treatment plans. It outlines the common clinical indications that drive device adoption and emphasizes the patient-experience improvements that contribute to adherence. Furthermore, it discusses how regulatory expectations and reimbursement dynamics influence clinical adoption, shaping device requirements for safety documentation, traceability, and interoperability with electronic medical records.

As the healthcare ecosystem shifts toward value-based outcomes and patient-centered care, CPM devices are increasingly assessed not only for their biomechanical performance but also for their capacity to support rehabilitation workflows, reduce caregiver burden, and enable remote monitoring. The introduction closes by framing the remaining sections: technological shifts, tariff impacts, segmentation nuances, regional dynamics, competitive positioning, actionable recommendations, methodology, and closing considerations designed to guide executive decisions.

A comprehensive exploration of how device engineering, digital connectivity, and shifting care delivery models are reshaping the continuous passive motion device market

The landscape is undergoing transformative shifts driven by advances in device design, digital integration, and care delivery models that together are redefining expectations for rehabilitation devices. Device manufacturers are incorporating modular designs and refined kinematic control to accommodate a broader range of joint anatomies and surgical protocols, enabling faster setup and reducing training demands for clinicians. At the same time, the infusion of sensors and connectivity into CPM platforms allows objective tracking of range-of-motion metrics, which clinicians can use to personalize therapy and report outcomes more transparently.

Concurrently, care delivery is decentralizing as more post-acute and rehabilitative services migrate from inpatient settings to outpatient clinics and home environments. This shift elevates the importance of portability, user-friendly interfaces, and battery efficiency in device selection criteria. Payment models and clinical protocols are adapting accordingly, with an increased emphasis on devices that support remote monitoring and data export for tele-rehabilitation programs.

Moreover, supply chain resilience and strategic sourcing have become central to competitive differentiation. Manufacturers and distributors are reevaluating production footprints, supplier relationships, and component standardization to mitigate disruption risks and improve margins. Taken together, these transformative shifts are driving convergence between mechanical reliability, digital capability, and service-oriented business models, altering how stakeholders evaluate product value and long-term partnerships.

An analytical assessment of how recent tariff shifts are influencing component sourcing, procurement strategies, and commercial models across the continuous passive motion device ecosystem

The cumulative impact of recent tariff developments affecting imports and components has introduced new operational considerations for manufacturers, distributors, and procuring institutions. Tariff adjustments alter landed costs for key components such as actuators, control electronics, and specialized plastics, prompting procurement teams to reexamine vendor contracts and total cost of ownership. In response, device manufacturers have accelerated efforts to qualify alternative suppliers, localize critical component manufacturing, and redesign assemblies to reduce reliance on tariff-affected parts.

These changes have cascading implications for contract negotiations and inventory strategies. Healthcare providers and group purchasing organizations increasingly include tariff exposure clauses and flexible sourcing requirements in long-term agreements. As a consequence, manufacturers that can demonstrate supply-chain transparency, multi-sourcing strategies, and component traceability gain a competitive advantage in procurement discussions.

Additionally, tariff-driven cost pressures have increased the appeal of service-based models, including subscription and managed-equipment offerings that shift capital expenditures into predictable operating expenses. This commercial flexibility can mitigate short-term pricing volatility for healthcare systems while maintaining access to advanced functionality. Ultimately, the tariff landscape is prompting a recalibration of supplier relationships, product design choices, and commercial models as stakeholders prioritize resilience, cost predictability, and continuity of care.

Detailed segmentation analysis revealing how end-user environments, anatomical applications, device configurations, and channel strategies determine product design and commercialization paths

Key segmentation insights reveal nuanced behavior across end users, applications, device types, and distribution channels, each influencing product requirements and commercial approaches. Based on End User, the market is studied across Clinics, Home Care, Hospitals, and Rehabilitation Centers, with Clinics further examined across Outpatient Clinics and Rehabilitation Clinics, and Hospitals further differentiated into Private Hospitals and Public Hospitals. This granularity shows that outpatient rehabilitation environments prioritize compact form factors and rapid setup, while inpatient and hospital contexts emphasize integration with clinical workflows and staff-managed safety features. Home care settings demand intuitive interfaces, clear safety interlocks, and remote-monitoring capabilities to support independent or caregiver-assisted use.

Based on Application, the market is studied across Ankle, Elbow, Knee, and Shoulder, and these anatomical distinctions drive product geometry, motion profiles, and accessory requirements. Knee applications typically necessitate robust range-of-motion programming and higher torque capacity, whereas shoulder and elbow solutions emphasize multi-axis articulation and stabilizing supports. Ankle solutions balance compactness with precise dorsiflexion and plantarflexion control to address postoperative mobility and tendon rehabilitation.

Based on Type, the market is studied across Bilateral and Unilateral configurations, which affect device complexity, portability, and price-performance equations; bilateral solutions often require synchronized motion control and broader support systems, while unilateral devices favor simplicity and lower footprint for targeted therapy. Based on Distribution Channel, the market is studied across Direct Sales, E-commerce, Retail, and Third-Party Distributors, with E-commerce further divided into Manufacturer Websites and Online Pharmacies and Third-Party Distributors further subdivided into Authorized Distributors and Independent Distributors. Distribution choices reflect buyer preferences for service levels, procurement timelines, and warranty or training bundles, and they shape how manufacturers design channel-specific SKUs and aftersales programs.

Comparative regional perspective outlining how clinical standards, regulatory regimes, and buyer preferences in major global regions shape adoption and commercialization strategies

Regional dynamics materially influence clinical adoption, regulatory expectations, and commercial execution across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, decision-making often emphasizes integration with multidisciplinary care teams and reimbursement alignment, driving demand for devices that can deliver documented functional outcomes and seamless interoperability with clinical systems. This region also favors service models that simplify procurement for larger health systems and outpatient networks.

In Europe, Middle East & Africa, regulatory harmonization in parts of Europe and varying approval pathways across the broader EMEA region require manufacturers to maintain flexible regulatory affairs strategies and localized documentation. Public procurement frameworks and central tenders in several countries place a premium on proven safety records, lifecycle cost considerations, and supplier reliability. In the Middle East and Africa, channel partnerships and distributor expertise are particularly important to navigate local contracting, installation, and training requirements.

The Asia-Pacific region presents a mix of advanced-care urban centers and emerging markets with growing access to rehabilitative services. Here, manufacturers must balance high-end feature sets demanded by tertiary hospitals with cost-efficient, scalable solutions for smaller clinics and home-based care. Rapidly evolving telehealth regulations and increasing digital health adoption across Asia-Pacific also create opportunities for devices that embed remote monitoring and analytics. Across all regions, successful market approaches blend clinical evidence, adaptable commercial models, and local support infrastructures.

Competitive company insights revealing how modular engineering, clinical partnerships, and service-oriented business models create sustained differentiation in device markets

Insights into key companies highlight strategic approaches to product development, partnerships, and service differentiation that influence competitive positioning. Leading device developers are investing in modular architectures that allow for incremental feature upgrades, enabling longer product lifecycles and simplified maintenance. They are also prioritizing human-centered design to reduce setup time for clinicians and to improve adherence in home environments, incorporating features such as quick-mount brackets, intuitive controls, and clear user feedback loops.

Beyond hardware, successful companies are bundling data services and outcome reporting that support value-based care discussions with payers and hospital procurement teams. Strategic partnership activity includes collaborations with rehabilitation providers, orthopedics groups, and technology firms to expand clinical validation and integrate remote monitoring capabilities. In addition, companies that have developed resilient manufacturing footprints and diversified supplier networks demonstrate greater agility when responding to supply-chain disruptions or tariff-driven cost shifts.

Commercially, firms differentiate through tailored service offerings such as training programs, extended warranties, managed equipment services, and subscription pricing that align with institutional budgeting cycles. Firms that combine clinical evidence, strong post-sales support, and channel depth are best positioned to capture long-term institutional relationships and to support scalable rollouts across multi-site healthcare systems.

Practical strategic and operational recommendations that companies can implement to accelerate adoption, strengthen supply resilience, and demonstrate clinical and commercial value

Actionable recommendations for industry leaders focus on product, commercial, and operational levers that can be implemented to deepen market access and operational resilience. First, prioritize modular design and configurable software that enable device variants to be tailored to outpatient, inpatient, and home-care use cases without costly redesigns. This approach reduces manufacturing complexity and accelerates time to deployment while meeting diverse clinical needs. Second, invest in embedded sensor suites and interoperable data platforms that provide objective recovery metrics, enabling clinicians to personalize therapy and demonstrate clinical value to payers and procurement committees.

Third, broaden supply-chain strategies by qualifying secondary suppliers for critical components, exploring nearshoring options for subassemblies, and establishing inventory buffers for high-risk parts. Fourth, develop channel strategies that align with buyer segmentation: support direct sales relationships for large institutional accounts while scaling digital and distributor channels to reach home-care and smaller clinic segments. Fifth, expand service portfolios to include managed equipment offerings, outcome-driven warranties, and training packages that reduce institutional friction and support long-term adoption.

Finally, pursue clinical evidence generation through focused trials and real-world evidence initiatives that document functional outcomes and patient-reported improvements. Coupled with clear value propositions, these steps position companies to respond to procurement scrutiny, adapt to tariff and supply pressures, and accelerate adoption across care settings.

A rigorous multi-source research methodology combining expert interviews, technical reviews, and supply-chain analysis to support evidence-based conclusions and reproducibility

The research methodology combines a multi-source evidence base, structured expert engagement, and rigorous qualitative synthesis to ensure robust and actionable findings. Primary inputs include structured interviews with clinicians, procurement leaders, device developers, and rehabilitation specialists to capture real-world device performance, workflow constraints, and adoption drivers. These engagements are complemented by technical reviews of device specifications, regulatory filings, and clinical guidance documents to validate feature requirements and compliance expectations.

Secondary inputs comprise an analysis of industry publications, white papers, and peer-reviewed clinical literature that document therapeutic outcomes associated with passive motion therapies and relevant device classes. Supply-chain assessments leverage customs and trade records, component sourcing data, and supplier disclosures to map dependencies and tariff exposure. Competitive landscaping relies on product literature, patents, and public filings to clarify technological differentiation and product road maps.

Data synthesis follows a transparent process: thematic coding of qualitative interviews, cross-validation against secondary sources, and iterative review with subject-matter experts to reconcile conflicting evidence. The methodology emphasizes reproducibility and traceability by documenting data sources, interview protocols, and analytical assumptions, and by providing stakeholders with the opportunity to validate findings during peer review sessions.

A concise conclusion synthesizing technological, commercial, and operational imperatives that will determine success in the evolving continuous passive motion device landscape

In conclusion, continuous passive motion devices occupy a pivotal role in modern rehabilitation ecosystems by bridging clinical protocols, patient experience, and evolving care delivery models. Advances in device engineering and digital integration are expanding therapeutic capabilities while simultaneously changing procurement expectations and channel dynamics. Tariff developments and supply-chain volatility add pressure but also create incentives for resilient sourcing, modular design, and service-oriented commercial models.

Segmentation analysis underscores the importance of tailoring product features and go-to-market strategies to distinct end users, anatomical applications, device configurations, and distribution channels. Regional dynamics further necessitate flexible regulatory and commercial approaches to address diverse reimbursement landscapes and institutional procurement processes. Competitive insights indicate that companies combining robust clinical evidence, flexible service models, and strong post-sales support are best positioned to secure long-term institutional relationships.

Taken together, these findings suggest that the most successful strategies will integrate technical innovation with operational resilience, focused clinical validation, and channel-aligned commercial models. By emphasizing patient outcomes, demonstrable value, and supply-chain agility, stakeholders can better navigate current market complexities and capitalize on opportunities to improve rehabilitation care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Joint Continuous Passive Motion Machine Market, by Type

  • 8.1. Bilateral
  • 8.2. Unilateral

9. Joint Continuous Passive Motion Machine Market, by Target Area

  • 9.1. Ankle
  • 9.2. Elbow
  • 9.3. Knee
  • 9.4. Shoulder

10. Joint Continuous Passive Motion Machine Market, by End User

  • 10.1. Clinics
    • 10.1.1. Outpatient Clinics
    • 10.1.2. Rehabilitation Clinics
  • 10.2. Home Care
  • 10.3. Hospitals
    • 10.3.1. Private Hospitals
    • 10.3.2. Public Hospitals
  • 10.4. Rehabilitation Centers

11. Joint Continuous Passive Motion Machine Market, by Distribution Channel

  • 11.1. Direct Sales
  • 11.2. E-commerce
    • 11.2.1. Manufacturer Websites
    • 11.2.2. Online Pharmacies
  • 11.3. Retail
  • 11.4. Third-Party Distributors
    • 11.4.1. Authorized Distributors
    • 11.4.2. Independent Distributors

12. Joint Continuous Passive Motion Machine Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Joint Continuous Passive Motion Machine Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Joint Continuous Passive Motion Machine Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Joint Continuous Passive Motion Machine Market

16. China Joint Continuous Passive Motion Machine Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Biodex Medical Systems, Inc.
  • 17.6. Bio-Med Inc.
  • 17.7. Bio-Medical Orthopaedic Equipment Suppliers
  • 17.8. Breg, Inc.
  • 17.9. Capital Medical Corporation
  • 17.10. Chinesport S.p.A.
  • 17.11. DePuy Synthes, Inc.
  • 17.12. DeRoyal Industries, Inc.
  • 17.13. DJO LLC
  • 17.14. Furniss Corporation
  • 17.15. HMS Medical Systems
  • 17.16. Kinex Medical Company, LLC
  • 17.17. Mediware Information Systems, Inc.
  • 17.18. Medi-Care Solutions Ltd.
  • 17.19. Medline Industries, Inc.
  • 17.20. OPED GmbH & Co. KG
  • 17.21. OrthoAgility Ltd.
  • 17.22. OrthoRehab, Inc.
  • 17.23. Rehab-Robotics Company Limited
  • 17.24. Smith & Nephew plc
  • 17.25. Stryker Corporation
  • 17.26. Surgi-Care, Inc.
  • 17.27. TheraMotion, LLC
  • 17.28. Zimmer Biomet Holdings, Inc.
  • 17.29. Ossur hf

LIST OF FIGURES

  • FIGURE 1. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY BILATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY BILATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY BILATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY UNILATERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY UNILATERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY UNILATERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ANKLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ANKLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ANKLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ELBOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ELBOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ELBOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY KNEE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY KNEE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY KNEE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY SHOULDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY SHOULDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY SHOULDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY OUTPATIENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY OUTPATIENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY OUTPATIENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY REHABILITATION CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY REHABILITATION CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY REHABILITATION CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY MANUFACTURER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY MANUFACTURER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY AUTHORIZED DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY AUTHORIZED DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY AUTHORIZED DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY INDEPENDENT DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 159. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 162. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 164. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 165. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 166. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 167. GCC JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 186. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 189. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 191. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 192. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 194. G7 JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 195. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 198. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 200. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 201. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 203. NATO JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY TARGET AREA, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY E-COMMERCE, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA JOINT CONTINUOUS PASSIVE MOTION MACHINE MARKET SIZE, BY THIRD-PARTY DISTRIBUTORS, 2018-2032 (USD MILLION)